BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1864269)

  • 1. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program.
    Myhr BC; Caspary WJ
    Environ Mol Mutagen; 1991; 18(1):51-83. PubMed ID: 1864269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity of rat-liver S9 to L5178Y mouse lymphoma cells.
    Myhr BC; Mayo JK
    Mutat Res; 1987 Sep; 189(1):27-37. PubMed ID: 3627149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
    Clive D; Turner N; Krehl R
    Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals.
    McGregor DB; Brown A; Cattanach P; Edwards I; McBride D; Caspary WJ
    Environ Mol Mutagen; 1988; 11(1):91-118. PubMed ID: 3338442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity of 6 oxime compounds in the salmonella/mammalian-microsome assay and mouse lymphoma TK +/- assay.
    Rogers-Back AM; Lawlor TE; Cameron TP; Dunkel VC
    Mutat Res; 1988 Feb; 204(2):149-62. PubMed ID: 3278206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic activity of fluorides in mouse lymphoma cells.
    Caspary WJ; Myhr B; Bowers L; McGregor D; Riach C; Brown A
    Mutat Res; 1987 Mar; 187(3):165-80. PubMed ID: 3102959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methapyrilene is a genotoxic carcinogen: studies on methapyrilene and pyrilamine in the L5178Y/TK +/- mouse lymphoma assay.
    Turner NT; Woolley JL; Hozier JC; Sawyer JR; Clive D
    Mutat Res; 1987 Nov; 189(3):285-97. PubMed ID: 3670332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1984 Feb; 125(2):291-306. PubMed ID: 6700611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay.
    McGregor DB; Edwards I; Riach CG; Cattanach P; Martin R; Mitchell A; Caspary WJ
    Mutagenesis; 1988 Nov; 3(6):485-90. PubMed ID: 3070287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: intralaboratory results for sixty-three coded chemicals tested at Litton Bionetics, Inc.
    Myhr BC; Caspary WJ
    Environ Mol Mutagen; 1988; 12 Suppl 13():103-94. PubMed ID: 3416838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: methods used and chemicals evaluated.
    Mitchell AD; Myhr BC; Rudd CJ; Caspary WJ; Dunkel VC
    Environ Mol Mutagen; 1988; 12 Suppl 13():1-18. PubMed ID: 3416837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the activities of benzo[a]pyrene, benzidine and ethyl methanesulphonate in the L5178Y TK +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols.
    Riach CG; Cattanach PJ; Howgate S; Shepherd W; McBride D; Edwards IW; McGregor DB; Combes RD
    Mutagenesis; 1990; 5 Suppl():35-44. PubMed ID: 2184319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Moore MM; Doerr CL
    Mutagenesis; 1990 Nov; 5(6):609-14. PubMed ID: 2263219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific gene mutations in L5178Y cells in culture.
    Clive D; McCuen R; Spector JF; Piper C; Mavournin KH
    Mutat Res; 1983 Jun; 115(2):225-51. PubMed ID: 6855786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the CHO/HGPRT+ and the L5178Y/TK+/- mutation assays using suspension treatment and soft agar cloning: results for 10 chemicals.
    Oberly TJ; Michaelis KC; Rexroat MA; Bewsey BJ; Garriott ML
    Cell Biol Toxicol; 1993; 9(3):243-57. PubMed ID: 8299003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds.
    Wangenheim J; Bolcsfoldi G
    Mutagenesis; 1988 May; 3(3):193-205. PubMed ID: 3045481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A statistical method for analysis of mouse lymphoma L5178Y cell TK locus forward mutation assay. Comparison of results among three laboratories.
    Irr JD; Snee RD
    Mutat Res; 1982 Oct; 97(5):371-92. PubMed ID: 7144804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test.
    Honma M; Hayashi M; Shimada H; Tanaka N; Wakuri S; Awogi T; Yamamoto KI; Kodani N; Nishi Y; Nakadate M; Sofuni T
    Mutagenesis; 1999 Jan; 14(1):5-22. PubMed ID: 10474816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microwell mutation assays: evaluation of ethylmethanesulphonate, benzo[a]pyrene and benzidine using the tk locus in L5178Y mouse lymphoma cells.
    Clay P; Cross MF
    Mutagenesis; 1990; 5 Suppl():45-54. PubMed ID: 2184320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.